Logo

Cancer Research UK Expands License for DNAStar's Sequencing Software

Jan 31, 2007
NEW YORK (GenomeWeb News) - DNAStar said yesterday that Cancer Research UK has expanded its site license for the company’s Lasergene sequence analysis software.
 
In November, CR-UK licensed Lasergene for use at its Lincoln’s Inn Field and Clare Hall laboratories.
  
The new three-year agreement allows the Cambridge Research Institute and the Paterson Institute for Cancer Research to use the software at their labs as well.
 
GATC Biotech is DNAStar’s distributor for European markets.
 
Financial terms of the agreement were not released.

Filed under

Informatics
Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.